With more than 80 percent of trial participants achieving clear or almost clear skin, nomelcitinib is positioning itself as a robust competitor in the psoriasis treatment landscape. The quest for a highly effective, oral, and safe treatment for autoimmune skin conditions has long been the primary
Ethiopia's strategy reflects a broader continental trend toward health security, where local production is viewed as the only viable path to effective public health response. By 2030, the nation intends to transition from a major importer of medical goods to a self-reliant manufacturing powerhouse,
The lack of a comprehensive federal privacy mandate means that a consumer's protection against location tracking depends entirely on their specific state of residence. In the current landscape, the ubiquitous smartphone has evolved into a sophisticated surveillance tool that meticulously logs every
Systemic deficiencies in the digital bidding portal allowed sensitive commercial data to remain exposed from February until discovery in August 2026. This catastrophic oversight compromised a high-stakes procurement process managed by HealthShare Victoria, which was tasked with securing a
Hims & Hers now faces a potential peptide opportunity with a changed enforcement outlook but no new clinical evidence. Health and Human Services Secretary Robert F. Kennedy Jr. has introduced a policy under which HHS would refrain from enforcement against specified providers compounding six
U.S. District Judge Zahid Quraishi has declined Novo’s bid to halt Eli Lilly’s advertising comparisons between Zepbound and Wegovy. The decision rejects Novo’s request for a preliminary injunction; the underlying false-advertising dispute remains unresolved. For biopharma leaders, the case raises a